Mia's Feed
Medical News & Research

Innovative In Vitro Model Sheds Light on How Tumor Cells Enter the Bloodstream

Innovative In Vitro Model Sheds Light on How Tumor Cells Enter the Bloodstream

Share this article

A cutting-edge in vitro model reveals the detailed mechanism by which tumor cell clusters penetrate blood vessel walls and facilitate metastasis, paving the way for new targeted therapies against cancer spread.

2 min read

Recent research published in iScience has advanced our understanding of how cancer cells metastasize through the bloodstream. Led by researchers from the University of Tokyo, Kanazawa University, and Kyorin University School of Medicine, the study introduces a sophisticated three-dimensional in vitro system that mimics blood vessels and tumor tissue. This model enables scientists to observe the precise process by which clusters of tumor cells—detached from primary tumors—manage to infiltrate blood vessels and contribute to metastasis.

Metastasis remains one of the most challenging aspects of cancer treatment, often responsible for the poor prognosis associated with advanced cancers. Although circulating tumor cells (CTCs) are known to be involved—especially clusters of these cells that circulate within the blood—the mechanisms behind their entry into blood vessels were not fully understood.

Using live-imaging techniques, the team positioned tumor organoids either adjacent to or slightly away from artificial blood vessels and watched their interactions in real-time. The findings revealed that tumor cell clusters actively migrate toward blood vessel walls, disrupting their structure to facilitate entry. High levels of transforming growth factor-beta (TGF-β) and activin were expressed in vessel wall cells during this migration, prompting endothelial-to-mesenchymal transition—a process that weakens the vessel wall and enables tumor clusters to invade.

This partial dismantling of vascular structures not only allows tumor clusters to intravasate but also promotes their dispersal via the bloodstream, fueling metastasis. The insights gained from this model are pivotal because they point to the potential for developing treatments that prevent tumor cell clusters from breaching blood vessel barriers. Such strategies could significantly improve outcomes for patients with advanced cancer.

Overall, this innovative in vitro system offers a powerful platform for further studying how tumor cells invade blood vessels and for testing targeted therapies aimed at halting metastasis. Source: [https://medicalxpress.com/news/2025-05-vitro-cancer-reveals-tumor-cells.html]

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

promising treatment for severe post-COVID syndrome in children using celiac disease drug

A groundbreaking study reveals that an experimental drug for celiac disease shows promise in treating severe post-COVID syndrome in children, offering new hope for MIS-C recovery.

Understanding Mucus Color: Does Yellow Mucus Require Antibiotics?

Learn how mucus color and consistency can indicate infections and when antibiotics may be necessary, helping you understand your health better.

Protein DNM1 Identified as Key Regulator in Ovarian Cancer Metastasis

Research identifies the protein DNM1 as a key regulator of ovarian cancer metastasis, offering new avenues for targeted therapy. Elevated DNM1 levels promote tumor spread by enhancing cell mobility via N-cadherin recycling, presenting promising treatment strategies.

Exploring the Potential of AI Chatbots in Health Behavior Change and Motivational Interviewing

Recent research highlights the potential of AI-powered chatbots and virtual agents to deliver motivational interviewing, supporting health behavior change through accessible, empathetic digital tools. While promising, further evaluation of efficacy and fidelity is needed to ensure lasting impact.